13F HOLDINGS REPORT
Privium Fund Management B.V.
Quarter ended Q3 2025 · Filed November 4, 2025 · Accession 0001754960-25-000748
Total Value
$556.3M
Positions
59
Other Managers
0
Confidential Omitted
No
Holdings (59)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TESLA INC | TSLA | 244,000 | $108.5M | 19.51% |
| 2 | SPOTIFY TECHNOLOGY S A | SPOT | 95,000 | $66.3M | 11.92% |
| 3 | SHOPIFY INC | SHOP | 415,000 | $61.7M | 11.09% |
| 4 | PALANTIR TECHNOLOGIES INC | PLTR | 200,000 | $36.5M | 6.56% |
| 5 | AMAZON COM INC | AMZN | 149,000 | $32.7M | 5.88% |
| 6 | SEA LTD | SE | 160,000 | $28.6M | 5.14% |
| 7 | COINBASE GLOBAL INC | COIN | 79,000 | $26.7M | 4.79% |
| 8 | UNIQURE NV | QURE | 386,000 | $22.5M | 4.05% |
| 9 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 473,951 | $16.3M | 2.94% |
| 10 | IONIS PHARMACEUTICALS INC | IONS | 248,894 | $16.3M | 2.93% |
| 11 | NVIDIA CORPORATION | NVDA | 81,000 | $15.1M | 2.72% |
| 12 | PROQR THRAPEUTICS N V | N71542109 | 4,998,287 | $10.6M | 1.91% |
| 13 | ADVANCED MICRO DEVICES INC | AMD | 60,000 | $9.7M | 1.75% |
| 14 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 289,804 | $8.7M | 1.57% |
| 15 | LEMONADE INC | LMND | 145,000 | $7.8M | 1.40% |
| 16 | BIOGEN INC | BIIB | 51,925 | $7.3M | 1.31% |
| 17 | AXSOME THERAPEUTICS INC | AXSM | 52,732 | $6.4M | 1.15% |
| 18 | IREN LIMITED | IREN | 130,000 | $6.1M | 1.10% |
| 19 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 305,972 | $5.8M | 1.04% |
| 20 | MERCK & CO INC | MRK | 64,393 | $5.4M | 0.97% |
| 21 | AST SPACEMOBILE INC | ASTS | 110,000 | $5.4M | 0.97% |
| 22 | ZAI LAB LTD | ZLAB | 132,189 | $4.5M | 0.81% |
| 23 | UROGEN PHARMA LTD | URGN | 196,622 | $3.9M | 0.71% |
| 24 | VERTEX PHARMACEUTICALS INC | VRTX | 8,300 | $3.3M | 0.58% |
| 25 | CRISPR THERAPEUTICS AG | CRSP | 40,000 | $2.6M | 0.47% |
| 26 | ABIVAX SA | AAVXF | 30,412 | $2.6M | 0.46% |
| 27 | AVIDITY BIOSCIENCES INC | 05370A108 | 53,000 | $2.3M | 0.42% |
| 28 | HIMS & HERS HEALTH INC | HIMS | 40,000 | $2.3M | 0.41% |
| 29 | KRYSTAL BIOTECH INC | KRYS | 12,170 | $2.1M | 0.39% |
| 30 | AMBEV SA | ABEV | 897,134 | $2.0M | 0.36% |
| 31 | ROIVANT SCIENCES LTD | ROIV | 126,923 | $1.9M | 0.35% |
| 32 | BIONTECH SE | BNTX | 19,000 | $1.9M | 0.34% |
| 33 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 197,458 | $1.7M | 0.31% |
| 34 | ACADIA PHARMACEUTICALS INC | ACAD | 70,400 | $1.5M | 0.27% |
| 35 | BEAM THERAPEUTICS INC | BEAM | 61,000 | $1.5M | 0.27% |
| 36 | ROCKET PHARMACEUTICALS INC | RCKTW | 432,760 | $1.4M | 0.25% |
| 37 | MEIRAGTX HLDGS PLC | MGTX | 163,000 | $1.3M | 0.24% |
| 38 | LEXEO THERAPEUTICS INC | LXEO | 192,356 | $1.3M | 0.23% |
| 39 | WAVE LIFE SCIENCES LTD | WVE | 170,000 | $1.2M | 0.22% |
| 40 | MODERNA INC | MRNA | 47,000 | $1.2M | 0.22% |
| 41 | SEABRIDGE GOLD INC | SA | 48,474 | $1.2M | 0.21% |
| 42 | PFIZER INC | PFE | 37,750 | $961,870 | 0.17% |
| 43 | ALX ONCOLOGY HLDGS INC | ALXO | 509,059 | $931,578 | 0.17% |
| 44 | VIZSLA SILVER CORP | VZLA | 204,654 | $884,105 | 0.16% |
| 45 | NOV INC | NOV | 63,876 | $846,357 | 0.15% |
| 46 | PAN AMERN SILVER CORP | 697900108 | 18,531 | $717,706 | 0.13% |
| 47 | SPROTT FDS TR | SII | 11,448 | $691,803 | 0.12% |
| 48 | SCHLUMBERGER LTD | SLB | 19,697 | $676,986 | 0.12% |
| 49 | RECURSION PHARMACEUTICALS IN | RXRX | 119,000 | $580,720 | 0.10% |
| 50 | SANDRIDGE ENERGY INC | SD | 50,392 | $568,422 | 0.10% |
| 51 | AUTOLUS THERAPEUTICS PLC | AUTL | 308,837 | $503,404 | 0.09% |
| 52 | TAYSHA GENE THERAPIES INC | TSHA | 134,900 | $441,123 | 0.08% |
| 53 | FATE THERAPEUTICS INC | FATE | 333,219 | $419,856 | 0.08% |
| 54 | VALARIS LTD | VAL-WT | 8,315 | $405,523 | 0.07% |
| 55 | NOBLE CORP PLC | NE-WT | 14,287 | $404,036 | 0.07% |
| 56 | TRANSOCEAN LTD | RIG | 102,000 | $318,240 | 0.06% |
| 57 | SIBANYE STILLWATER LTD | SBYSF | 26,232 | $294,848 | 0.05% |
| 58 | TIDEWATER INC NEW | TDGMW | 5,483 | $292,408 | 0.05% |
| 59 | VOYAGER THERAPEUTICS INC | VYGR | 45,000 | $210,150 | 0.04% |